Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Response Genetics grosses $3.9mm through PIPE

Executive Summary

Response Genetics Inc. (PCR-based genetic tests for cancer) grossed $3.9mm through the sale of 3mm common shares at $1.31 each (a 7% premium) to Greenway Capital and associated funds (lead), Lansdowne Partners, and Paragon Associates.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Biotech
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register